Glenn Vergauwen

ORCID: 0000-0002-2213-163X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Advanced Biosensing Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Prostate Cancer Treatment and Research
  • Breast Cancer Treatment Studies
  • Endometrial and Cervical Cancer Treatments
  • Cancer Cells and Metastasis
  • Advanced Radiotherapy Techniques
  • Salivary Gland Tumors Diagnosis and Treatment
  • Erythrocyte Function and Pathophysiology
  • Nanopore and Nanochannel Transport Studies
  • Cell Adhesion Molecules Research
  • Characterization and Applications of Magnetic Nanoparticles
  • Cancer survivorship and care
  • Phytoestrogen effects and research
  • RNA modifications and cancer
  • Metastasis and carcinoma case studies
  • BRCA gene mutations in cancer
  • Nanofabrication and Lithography Techniques
  • Aldose Reductase and Taurine
  • Breast Lesions and Carcinomas
  • Advanced biosensing and bioanalysis techniques
  • Cardiac Ischemia and Reperfusion

Ghent University Hospital
2017-2024

Ghent University
2017-2023

Cancer Research Institute Ghent
2017-2023

Jan Van Deun Pieter Mestdagh Patrizia Agostinis Özden Akay Sushma Anand and 90 more Jasper Anckaert Zoraida Andreu Martínez Tine Baetens Els Beghein Laurence Bertier Geert Berx Janneke Boere Stephanie Boukouris Michel Bremer Dominik Buschmann James Brian Byrd Clara Casert Lesley Cheng Anna Cmoch Delphine Daveloose Eva De Smedt Şeyma Demirsoy Victoria Depoorter Bert Dhondt Tom A. P. Driedonks Aleksandra M. Dudek Abdou ElSharawy Ilaria Floris Andrew D. Foers Kathrin Gärtner Abhishek D. Garg Edward Geeurickx Jan Gettemans Farzaneh Ghazavi Bernd Giebel Tom Groot Kormelink Grace Hancock Hetty Helsmoortel Andrew F. Hill Vincent Hyenne Hina Kalra David Kim Joanna Kowal Sandra Kraemer Petra Leidinger Carina Leonelli Yaxuan Liang Lien Lippens Shu Liu Alessandra Lo Cicero Shaun Martin Suresh Mathivanan Prabhu Mathiyalagan Tamás Matusek Gloria Milani Marta Tortajada Liselot Mus Dillon C. Muth Andrea H. Németh Esther N. M. Nolte‐‘t Hoen Lorraine O’Driscoll Roberta Palmulli Michael W. Pfaffl Bjarke Primdal-Bengtson Erminia Romano Quentin Rousseau Susmita Sahoo Natália G. Sampaio Monisha Samuel Benjamin J. Scicluna Bieke Soen Anneleen Steels Johannes V. Swinnen Maarit Takatalo Safia Thaminy Clotilde Théry Joeri Tulkens Isabel Van Audenhove Susanne van der Grein Alan Van Goethem Martijn J. C. van Herwijnen Guillaume van Niel Nadine Van Roy Alexander R. van Vliet Niels Vandamme Suzanne Vanhauwaert Glenn Vergauwen Frederik J. Verweij Annelynn Wallaert Marca H. M. Wauben Kenneth W. Witwer Marijke I. Zonneveld Olivier De Wever Jo Vandesompele An Hendrix

10.1038/nmeth.4185 article EN Nature Methods 2017-02-28

Abstract Identification and validation of extracellular vesicle (EV)-associated biomarkers requires robust isolation characterization protocols. We assessed the impact some commonly implemented pre-analytical, analytical post-analytical variables in EV research. Centrifugal filters with different membrane types pore sizes are used to reduce large volume biofluids prior or concentrate EVs. compared five reported for their efficiency when using plasma, urine EV-spiked PBS. Regenerated...

10.1038/s41598-017-02599-y article EN cc-by Scientific Reports 2017-05-26

Abstract Recent years have seen an increase of extracellular vesicle (EV) research geared towards biological understanding, diagnostics and therapy. However, EV data interpretation remains challenging owing to complexity biofluids technical variation introduced during sample preparation analysis. To understand mitigate these limitations, we generated trackable recombinant (rEV) as a reference material. Employing complementary characterization methods, demonstrate that rEV are stable bear...

10.1038/s41467-019-11182-0 article EN cc-by Nature Communications 2019-07-23

ABSTRACT Extracellular vesicles (EV) are increasingly being recognized as important vehicles of intercellular communication and promising diagnostic prognostic biomarkers in cancer. Despite this enormous clinical potential, the plethora methods to separate EV from biofluids, providing material highly variable purity, lacking knowledge regarding methodological repeatability pose a barrier translation. Urine is considered an ideal proximal fluid for study urological cancers due its direct...

10.1080/20013078.2020.1736935 article EN cc-by-nc Journal of Extracellular Vesicles 2020-03-11

Separating extracellular vesicles (EV) from blood plasma is challenging and complicates their biological understanding biomarker development. In this study, we fractionate by combining size-exclusion chromatography (SEC) OptiPrep density gradient centrifugation to study clinical context-dependent time-dependent variations in the biomolecular landscape of systemically circulating EV. Using pooled samples breast cancer patients, first demonstrate technical repeatability fractionation. serial...

10.1002/jev2.12122 article EN Journal of Extracellular Vesicles 2021-08-01

Abstract The analysis of extracellular vesicles (EV) in blood samples is under intense investigation and holds the potential to deliver clinically meaningful biomarkers for health disease. Technical variation must be minimized confidently assess EV‐associated biomarkers, but impact pre‐analytics on EV characteristics remains minimally explored. We present results from first large‐scale Blood Benchmarking (EVBB) study which we systematically compared 11 collection tubes (BCT; six preservation...

10.1002/jev2.12315 article EN cc-by-nc-nd Journal of Extracellular Vesicles 2023-05-01
Michalis Kontos Prodromos Kanavidis Thorsten Kühn Yazan Masannat Bahadır M. Gūllūoḡlu and 95 more Eduardo González Melanie Walker A. J. Collins M Nano Kim Heron Beth Penington Mike He Norman C. Janu Katrina Read Jose Cid Fernandez Belinda Brown Aashit Shah Kylie Snook Sarah Forsyth Janne Bingham Jocelyn Lippey Joel Symonds Alec A. Winder Nita Bartlett P. Vujovic Jenny Gough Sarah Birks Farid Meybodi Saud Hamza Elisabeth Elder Heidi Stranzl Tahmina Kosayeva Glenn Vergauwen Jaime Letzkus Gilberto Benitez Eduardo Cabrera Evros Kitiris Michalis Kailides Patricio Corral Khaled Mohamed Abdelwahab Ali Laura Niinikoski K. Weinand Stephan Hasmüller Conny Kurz Hans‐Christian Kolberg I. Thalmann Maggie Banys‐Paluchowski Aikaterini Manika Vasileios Venizelos Γεώργιος Μεταξάς Lazaros Papadopoulos Ioannis Natsiopoulos Eleftheria Ignatiadou R. Iosifidou Ioannis Askoksilakis Nikolaos V. Michalopoulos Grigorios Xepapadakis Serena Yu Yan Wong Karishma Kirti Roghieh Nooripour Alessandra Invento L. Regolo Corrado Chiappa Maria-Grazia Lazzaretti Andrea Sibilio Viviana-Enrica Galimberti Denise Mattar Silvia Michieletto Rosa Di Micco Teresa Di Palma Oreste ­Gentilini Nicola Rocco Mauro Porpiglia Mervat Al-Saleh Ibtisam Al‐Bader Sergio Aguilar-Villanueva Emiel Rutges Éva Juhász Nicola Davis Stan Govender Khaled Sharaf Lia Pamela Rebaza Vasquez Aldine Basa Dawid Murawa David Pinto Bonci Eduard-Alexandru Florin Bobîrcă Elena Toma Bogdan Diaconescu Radu Mirică Adrian Udrea Silvia Brotea-Mosoiu Gabriel Dimofte Lunca Sorinel Octav Ginghină G Alexandru Mihai-Stefan Muresan Ana-Maria Muşină L Alriyees Chi Wei Mok

10.1007/s10549-023-07204-7 article EN Breast Cancer Research and Treatment 2024-01-04
Giacomo Montagna Alison Laws Massimo Ferrucci Mary Mrdutt Susie X. Sun and 95 more Süleyman Bademler Hakan Balbaloğlu Nora Balint‐Lahat Malgorzata Banys-Paluchowski Andrea V. Barrio John R. Benson Nuran Beşe Judy C. Boughey Marissa K. Boyle Emilia J. Diego Claire Eden Ruth Eller Maite Goldschmidt Callie Hlavin Martin Heidinger Justyna Jelinska Güldeniz Karadeniz Çakmak Susan B. Kesmodel Tari A. King Henry M. Kuerer Julie M Loesch Francesco Milardi Dawid Murawa Tracy‐Ann Moo Tehillah S. Menes Daniele Passeri Jessica Pastoriza Andraž Perhavec Nina Pislar Natália Polidorio Avina Rami Jai Min Ryu Alexandra Schulz Varadan Sevilimedu Mustafa Ümit Uğurlu Cihan Uras Annemiek K. E. van Hemert Stephanie M. Wong Tae-Kyung Yoo Jennifer Q. Zhang Hasan Karanlık Neslihan Cabıoğlu Marie-Jeanne T. F. D. Vrancken Peeters Monica Morrow William P. Weber Sung Gwe Ahn Mariacarla Andreozzi Daniel Meirelles Barbalho J.-F. Boileau Edi Brogi Flávia Vidal Cabero Daniela Cocco Fabio Corsi Angelena Crown Eelco de Bree M. Vernet-Tomás Christine Deutschmann Nina Ditsch Emanuela Esposito Oluwadamilola M. Fayanju Franziska Fick Florian Fitzal Meghan R. Flanagan Damiano Gentile Oreste ­Gentilini Anne Grabenstetter Mehmet Ali Gülçelik Jörg Heil Johannes Holtschmidt Natalia Krawczyk Thorsten Kühn Sherko Kümmel Cornelia Leo Mahmut Muslumanoglu Valentina Nekljudova Lisa A. Newman Melissa Pilewskie Nikiforita Poulakaki Fabian Riedel Nicola Rocco Freya Schnabel Christopher J. Schwartz Emily Siegel Colin Simonson Christian F. Singer Leonardo Ribeiro Soares Ekaterini Christina Tampaki Athanasios Tampakis Marios Konstantinos Tasoulis Christoph Tausch Cícero Úrban Astrid Botty van den Bruele Glenn Vergauwen Denise Vorburger Fredrik Wärnberg

The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management not standardized. We investigated rates additional positive (LNs) at node dissection (ALND) oncologic outcomes ypN0i+ treated without ALND.

10.1200/jco.24.01052 article EN Journal of Clinical Oncology 2024-11-07

Breast cancer cells closely interact with different cell types of the surrounding adipose tissue to favor invasive growth and metastasis. Extracellular vesicles (EVs) are nanometer-sized secreted by that shuttle proteins nucleic acids establish cell-cell communication. To study role EVs released cancer-associated in breast progression metastasis a standardized EV isolation protocol obtains pure maintains their functional characteristics is required. We implemented differential...

10.1080/19336918.2017.1279784 article EN Cell Adhesion & Migration 2017-02-01

In the surgical treatment of breast cancer, primary tumor is removed together with sentinel lymph nodes (SLNs). Current clinical procedures involve radioactive compounds (exposing both patient and surgeon) blue dyes, which often induce long-lasting skin discoloration. Here, we demonstrate in vivo detection SLNs mice using X-ray computed tomography (CT) near-infrared fluorescence via a dual-modality imaging probe. CT contrast provided by hafnium oxide nanocrystals, stabilized physiological...

10.1021/acs.chemmater.3c01324 article EN Chemistry of Materials 2023-10-30

Extracellular vesicles (EV) are extensively studied in human body fluids as potential biomarkers for numerous diseases. Major impediments of EV-based biomarker discovery include the specificity and reproducibility EV sample preparation well intensive manual labor. We present an automated liquid handling workstation density-based separation from compare its performance to by (in)experienced researchers.Automated versus trackable recombinant extracellular (rEV) spiked PBS significantly reduces...

10.1186/s12951-023-01917-z article EN cc-by Journal of Nanobiotechnology 2023-05-19

Background: The prognostic and predictive role of stromal tumor-infiltrating lymphocytes (sTILs) is undetermined in pleomorphic invasive lobular cancer (pILC). same applies for the expression PD-1/PD-L1 this rare breast subtype. Here, we aimed to investigate sTILs, analyze PD-L1 levels pILC.
 Methods: Archival tissues from sixty-six patients with pILC were collected. sTIL density was scored as a percentage tumor area, using following cut-offs: 0%; <5%; 5-9%; 10-50%. analyzed IHC...

10.20944/preprints202304.1090.v1 preprint EN 2023-04-28

Neo-adjuvant radiotherapy (NART) for breast cancer has shown promising survival results in retrospective trials. However, there are some obstacles such as a chemotherapy delay, an increased overall treatment time (OTT) and the risk of increasing surgical morbidity. Accelerated (RT) 5 fractions allows to deliver NART very short span minimizes delay surgery chemotherapy. This trial investigates this schedule safety, feasibility OTT.Twenty patients eligible neo-adjuvant (NACT) conserving...

10.1016/j.breast.2022.01.010 article EN The Breast 2022-01-20

Introduction Breast cancer is the most common type in women worldwide. Due to hormone receptor positivity majority of breast tumours endocrine therapy a crucial part treatment landscape cancer. Endocrine consists use selective oestrogen-receptor modulators or aromatase inhibitors. These medicines generate hypoestrogenic environment by reducing circulating oestrogen altering effect on tissue cells blockade. As side effect, vulvovaginal atrophy occurs patients with using therapy. Vulvovaginal...

10.1136/bmjopen-2022-068053 article EN cc-by-nc BMJ Open 2023-04-01

Background: The prognostic and predictive role of stromal tumor-infiltrating lymphocytes (sTILs) is undetermined in pleomorphic invasive lobular cancer (pILC). same applies for the expression PD-1/PD-L1 this rare breast subtype. Here, we aimed to investigate sTILs analyze PD-L1 levels pILC. Methods: Archival tissues from sixty-six patients with pILC were collected. sTIL density was scored as a percentage tumor area using following cut-offs: 0%; <5%; 5–9%; 10–50%. analyzed IHC on...

10.3390/cancers15112894 article EN Cancers 2023-05-24

<h3>Introduction/Background</h3> Vulvar cancer is a rare malignancy. Treatment in the early stages consists of broad excision and sentinel node procedure. Tumour remains challenging due to high risk local recurrence (43%) associated with positive tumour margins. Therefore, precise method preserve healthy tissue detect margins intra-operatively, needed. Direct intra-operative assessment would avoid need for re-operation their psychological, technical, financial consequences. Currently, margin...

10.1136/ijgc-2024-esgo.1096 article EN 2024-03-01

Abstract Background: Breast cancer is the most common type in women worldwide. Due to hormone receptor positivity majority of breast tumors endocrine therapy a crucial part treatment landscape cancer. Selective estrogen-receptor modulators or aromatase inhibitors are used options for therapy. These medicines generate hypoestrogenic environment by reducing circulating estrogen altering effect on tissue cells blockade. As side effect, vulvovaginal atrophy occurs patients using Vulvovaginal has...

10.1158/1538-7445.sabcs23-po4-27-04 article EN Cancer Research 2024-05-02
Coming Soon ...